A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

907

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

December 20, 2021

Study Completion Date

February 18, 2022

Conditions
Hypertension, Pulmonary
Interventions
OTHER

Blood Sample

Prevalent (existing) and incident (new) participants who are found to either have PH or not by RHC will provide blood sample for the establishment of a biomarker signature of PH.

Trial Locations (49)

1070

ULB Erasme Ziekenhuis, Brussels

3000

UZ Leuven Gasthuisberg, Leuven

8035

Hosp Univ Vall D Hebron, Barcelona

8036

Hosp Clinic de Barcelona, Barcelona

10029

Icahn School of Medicine at Mount Sinai, New York

13088

Pulmonary Health Physicians, PC, Liverpool

18009

CNE 'Cherkasy Regional Cardiological Center of Cherkasy Regional Council', Cherkasy

23230

Pulmonary Associates Of Richmond, Richmond

23538

Universitatsklinikum Schleswig Holstein, Lübeck

28041

Hosp. Univ. 12 de Octubre, Madrid

29200

CHU de Brest - Hopital de la Cavale Blanche, Brest

31059

Hopital Larrey CHU de Toulouse, Toulouse

32204

Ascension St. Vincent's Lung Institute, Jacksonville

32224

Mayo Clinic, Jacksonville

34295

CHU de Montpellier - Arnaud de Villeneuve, Montpellier

34376

Lungenfachklinik Immenhausen, Immenhaus

35392

Universitaetsklinikum Giessen, Giessen

37008

Hosp Clinico Univ de Salamanca, Salamanca

39008

Hosp. Univ. Marques de Valdecilla, Santander

40202

Norton Pulmonary Specialists, Louisville

45004

Hosp. Virgen de La Salud, Toledo

45267

University of Cincinnati, Cincinnati

49070

CE 'Dnipropetrovsk Regional Clinical Center of Cardiology and Cardiosurgery', Dnipro

52242

University Of Iowa - Hospitals & Clinics, Iowa City

53105

Universitatsklinikum Bonn, Bonn

55905

Mayo Clinic, Rochester

59037

Hôpital Cardiologique - Chru Lille, Lille

69126

Thoraxklinik Heidelberg, Heidelberg

70112

LSU Health Sciences Center New Orleans, New Orleans

77030

The Houston Methodist Research Institute, Houston

90033

University of Southern California, Los Angeles

94270

Hopital de Bicetre, Le Kremlin-Bicêtre

80045-2548

University Of Colorado Cardiac And Vascular Center, Aurora

02111-1552

Tufts Medical Center, Boston

68198-5990

University of Nebraska Medical Center, Omaha

75390-8550

UT Southwestern Medical Center, Dallas

01307

Universitätsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik 1-Pneumologie, Dresden

07747

Universitätsklinikum Jena Klinik für Innere Medizin I, Jena

1007 MB

VUMC Amsterdam, Amsterdam

20 718

Wojewodzki Szpital Specjalistyczny im Stefana Kardynala Wyszynskiego, Lublin

05 400

Europejskie Centrum Zdrowia Otwock Sp z o o, Otwock

70-111

Samodzielny Publiczny Szpital Kliniczny nr 2 PUM, Szczecin

02000

SI National Scientific Center Institute of Cardiology of M.D. Strazhesko of NAMS of Ukraine, Kyiv

03038

SI 'National Institute of Phtisiology and Pulmonology n.a. F.G. Yanovsky of NAMS of Ukraine', Kyiv

BA1 3NG

Royal United Hospital, Bath

G81 4DY

National Waiting Times Centre Board Golden Jubilee National Hospital, Glasgow

NW3 2QG

Royal Free Hospital, London

W12 0HS

Hammersmith Hospital, London

S10 2RX

Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital, Sheffield

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04193046 - A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) | Biotech Hunter | Biotech Hunter